14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Rubius Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Rubius Therapeutics Inc. is RUBY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rubius Therapeutics Inc. Stock?
Rubius Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Rubius Therapeutics Inc. Stock?
Rubius Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rubius Therapeutics Inc. Stock.

What's the current price of Rubius Therapeutics Inc. Stock?
As of the end of day on the Mar 28, 2024, the price of an Rubius Therapeutics Inc. (RUBY) share was $0.0570.

What is the 52-week high and low for Rubius Therapeutics Inc. Stock?
The 52-week high for Rubius Therapeutics Inc. Stock is $0.0360 and the 52-week low is $0.0180.

What is the market capitalization of Rubius Therapeutics Inc. Stock?
As of the Mar 28, 2024, the market capitalization of Rubius Therapeutics Inc. is 5.158M.
Click to get the best stock tips daily for free!

About Rubius Therapeutics Inc.

Rubius Therapeutics. Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 201... RUBY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT